Zydus Lifesciences has informed that this is in furtherance of earlier intimation dated May 8, 2026, about the meeting of the Board of Zydus Lifesciences (the Company) scheduled to be held on Tuesday, May 19, 2026. In terms of Regulation 29(1)(b) and Regulation 29(2) of the Listing Regulations, the Board of the Company, at its aforesaid meeting, will also consider the proposal for buyback of fully paid-up equity shares of the Company and the matters necessary and incidental thereto, in accordance with the applicable provisions under the Companies Act, 2013, as amended, (including the rules and regulations framed thereunder), the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018, as amended, and other applicable laws. As intimated earlier, the trading window as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed till Thursday, May 21, 2026, and shall open for trading on and from Friday, May 22, 2026, for all the Directors and Designated Persons of the Company. The trading window shall be deemed to be closed in respect of the aforementioned buyback proposal as well, in accordance with applicable laws.
The above information is a part of company’s filings submitted to BSE.
